Back in the late 1990's, SmartGene's founders envisioned that realizing the promise of routine genetic analysis would require comprehensive, data management solutions (covering all steps to generate meaningful results).
Consequently, SmartGene was founded in 1998 as a privately-held company to develop, market, and support application services for the analysis and management of complex genetic data.
SmartGene has its worldwide headquarters in Switzerland. SmartGene's North American operations opened in the Research Triangle Park area of North Carolina in 2006.
SmartGene’s proprietary technology, the Integrated Database Network System (IDNS) combines Web and database capabilities with advanced bioinformatics and relevant genetic content in application-specific suites.
Currently available modules from SmartGene include: identification of bacteria and fungi by sequence analysis; genotyping and drug resistance of HIV, HCV, and influenza; multilocus sequence typing (MLST) for epidemiology of viruses and bacteria; HLA typing, and certain genetically coded diseases. Since the platform and layout of all modules are similar, users can easily switch between applications with minimal additional training.
Over the years, SmartGene has gained a broad customer base for which it has constantly enhanced its services. Customers of SmartGene include diagnostic centers, clinical reference labs, academic medical centers, public health laboratories, S&P 500 companies, research centers, and national networks of sites collaborating in clinical genomics.
Beyond its use in the laboratory, the IDNS platform enables users from different organizations and in multiple locations to network and share data securely online.
SmartGene's commitment is to provide first-class service to a rapidly growing community of scientists involved in the analysis of complex genetic data. We strive to keep our customers in step with evolving science, to enhance the accuracy of genetic interpretation, and to make it easier to generate meaningful results.